Background Sudden cardiac death (SCD) is frequent in patients with heart failure due to
dilated cardiomyopathy (DCM). Implantable cardioverter/defibrillator (ICD) device therapy is …

Background: Recent clinical trials highlight the need for better models to identify patients at
higher risk of sudden death. Objectives: The authors hypothesized that the Seattle Heart …

Background Implantable cardioverter defibrillators (ICD s) have proved their favorable
outcomes on survival in selected patients with cardiomyopathy. Although previous meta …

Abstract Aims Implantable cardioverter defibrillators (ICDs) are an effective primary
prevention of sudden cardiac death. We examined whether dual-chamber (DC) ICDs confer …

Objectives: In this study, the authors developed the Seattle Proportional Risk Model (SPRM)
to estimate the proportion of total mortality due to sudden death. We prospectively validated …

Background Health insurance has many benefits including improved financial security,
greater access to preventive care, and better selfperceived health. However, the influence …

Background There is evidence that the benefit of a primary prophylactic ICD therapy is not
equal in all patients. Purpose To evaluate risk factors of appropriate shocks and all-cause …

Participation in organized sport and recreational activities presents an innate risk for serious
morbidity and mortality. Although death during sport or physical activity has many causes …

Objective: Implantable cardioverter-defibrillator has become the first-line therapy for
prevention of sudden cardiac death. Controversial results still exist regarding the …

Sudden cardiac death (SCD) risk assessment among patients with nonischemic
cardiomyopathy (NICM) has been has been less straightforward than for patients with …